Rekha Hemrajani, Director at MAXCYTE, INC. (MXCT), sold 10,684 shares at $2.09 ($22K) on 2025-06-25, disclosed to the SEC on 2025-08-27.
Scheduled sale ($22k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ALXO | BUY | 2020-07-21 | $57K | — | Filing → |